Scozzafava A, Supuran C T
Università degli Studi, Laboratorio di Chimica Inorganica e Bioinorganica, Florence, Italy.
Bioorg Med Chem. 2000 Mar;8(3):637-45. doi: 10.1016/s0968-0896(99)00316-8.
A series of hydroxamates was prepared by reaction of alkyl/arylsulfonyl halides with N-2-chlorobenzyl-L-alanine, followed by conversion of the COOH moiety to the CONHOH group, with hydroxylamine in the presence of carbodiimides. Other structurally related compounds were obtained by reaction of N-2-chlorobenzyl-L-alanine with aryl isocyanates, arylsulfonyl isocyanates or benzoyl isothiocyanate, followed by the similar conversion of the COOH into the CONHOH moiety. The new compounds were assayed as inhibitors of the Clostridium histolyticum collagenase, ChC (EC 3.4.24.3), a bacterial zinc metallo-peptidase which degrades triple helical collagen as well as a large number of synthetic peptides. The prepared hydroxamate derivatives proved to be 100-500 times more active collagenase inhibitors than the corresponding carboxylates. Substitution patterns leading to best ChC inhibitors (both for carboxylates as well as for the hydroxamates) were those involving perfluoroalkylsulfonyl- and substituted-arylsulfonyl moieties, such as pentafluorophenylsulfonyl; 3- and 4-protected-aminophenylsulfonyl-; 3- and 4-carboxyphenylsulfonyl-; 3-trifluoromethyl-phenylsulfonyl; as well as 1- and 2-naphthyl-, quinoline-8-yl- or substituted-arylsulfonylamidocarboxyl moieties among others. Similarly to the matrix metalloproteinase (MMP) hydroxamate inhibitors, ChC inhibitors of the type reported here must incorporate hydrophobic moieties at the P2' and P3' sites, in order to achieve tight binding to the enzyme. This study also proves that the 2-chlorobenzyl moiety, investigated here for the first time, is an efficient P2' anchoring moiety for obtaining potent ChC inhibitors.
通过烷基/芳基磺酰卤与N - 2 - 氯苄基 - L - 丙氨酸反应制备了一系列异羟肟酸酯,随后在碳二亚胺存在下,用羟胺将COOH部分转化为CONHOH基团。通过N - 2 - 氯苄基 - L - 丙氨酸与芳基异氰酸酯、芳基磺酰异氰酸酯或苯甲酰异硫氰酸酯反应,随后将COOH类似地转化为CONHOH部分,得到了其他结构相关的化合物。对这些新化合物作为溶组织梭菌胶原酶ChC(EC 3.4.24.3)的抑制剂进行了测定,ChC是一种细菌锌金属肽酶,可降解三螺旋胶原以及大量合成肽。所制备的异羟肟酸酯衍生物被证明是相应羧酸盐的100 - 500倍活性的胶原酶抑制剂。导致最佳ChC抑制剂(对于羧酸盐以及异羟肟酸酯都是如此)的取代模式是那些涉及全氟烷基磺酰基和取代芳基磺酰基部分的模式,例如五氟苯基磺酰基;3 - 和4 - 保护氨基苯基磺酰基;3 - 和4 - 羧基苯基磺酰基;3 - 三氟甲基苯基磺酰基;以及1 - 和2 - 萘基、喹啉 - 8 - 基或取代芳基磺酰氨基羧基部分等。与基质金属蛋白酶(MMP)异羟肟酸酯抑制剂类似,本文报道的这类ChC抑制剂必须在P2'和P3'位点引入疏水部分,以便与酶紧密结合。本研究还证明,本文首次研究的2 - 氯苄基部分是获得强效ChC抑制剂的有效P2'锚定部分。